Nowak's right on this one. Next (announcement of) dilution would most likely be December or January at earliest, plenty of time for "good news," if any is possible at this point, and that's assuming SB doesn't shoot the company in foot in the meantime (which he's been known to do frequently). Q3 CC in October will be another great "pump" job or it'll probably kill the stock for 2 more years (or longer). Much depends not only "when" they schedule the FDA meeting BUT how it actually goes. If they push the meeting out 4 to 6 months by requesting a "B" or "C" type, dilution is fairly assured. Every December there's a "tax dump" anyway, so the timing is debatable but that timing is far more debatable than the likelihood of more "usury" of shareholder trust. Consistent deceptions and distortions of fact by management will continue. One may choose to trust or not but trading this stock like a game of "hot potato" is probably the best opinion I'd share publicly.
3 false statements based on reason and logic. there goes the sincerity I thought you once had. it is too bad because your recent posts reek of desperation. you must have an average price of around 2.50,,,jmo, and still bol to you.
here is a fact for you to consider:
"In 2007, 60.2% of the respondents claimed heroin or morphine as their first injected drug. This percentage had declined to 51.3% in 2010, but in contrast the incidence of buprenorphine as the first injected or abused drug by the study population increased from 30.5% (2007) to 44.4% (2010)."